EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Role of CFTR in diabetes‐induced pancreatic ductal fluid and HCO 3 − secretion

Attila Ébert iD, Eleonóra Gál, Emese Tóth, Titanilla Szögi, Péter Hegyi iD, Viktória Venglovecz iD

The Journal of Physiology · 2024

DOI: 10.1113/jp285702 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Physiology, 2024. Verfasst von Attila Ébert und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Pharmacotherapy, University of Szeged, Szeged, Hungary. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CF-Trust CFRD-SRC, National Research, Development and Innovation Office.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 1 diabetes is a disease of the endocrine pancreas; however, it also affects exocrine function. Although most studies have examined the effects of diabetes on acinar cells, much less is known regarding ductal cells, despite their important protective function in the pancreas. Therefore, we investigated the effect of diabetes on ductal function. Diabetes was induced in wild‐type and cystic fibrosis transmembrane conductance regulator (CFTR) knockout mice following an i.p. administration of streptozotocin. Pancreatic ductal fluid and HCO 3 − secretion were determined using fluid secretion measurements and fluorescence microscopy, respectively. The expression of ion transporters was measured by real‐time PCR and immunohistochemistry. Transmission electron microscopy was used for the morphological characterization of the pancreas. Serum secretin and cholecystokinin levels were measured by an enzyme‐linked immunosorbent assay. Ductal fluid and HCO 3 − secretion, CFTR activity, and the expression of CFTR, Na + /H + exchanger‐1, anoctamine‐1 and aquaporin‐1 were significantly elevated in diabetic mice. Acute or chronic glucose treatment did not affect HCO 3 − secretion, but increased alkalizing transporter activity. Inhibition of CFTR significantly reduced HCO 3 − secretion in both normal and diabetic mice. Serum levels of secretin and cholecystokinin were unchanged, but the expression of secretin receptors significantly increased in diabetic mice. Diabetes increases fluid and HCO 3 − secretion in pancreatic ductal cells, which is associated with the increased function of ion and water transporters, particularly CFTR. image Key points There is a lively interaction between the exocrine and endocrine pancreas not only under physiological conditions, but also under pathophysiological conditions The most common disease affecting the endocrine part is type‐1 diabetes mellitus (T1DM), which is often associated with pancreatic exocrine insufficiency Compared with acinar cells, there is considerably less information regarding the effect of diabetes on pancreatic ductal epithelial cells, despite the fact that the large amount of fluid and HCO 3 − produced by ductal cells is essential for maintaining normal pancreatic functions Ductal fluid and HCO 3 − secretion increase in T1DM, in which increased cystic fibrosis transmembrane conductance regulator activation plays a central role. We have identified a novel interaction between T1DM and ductal cells. Presumably, the increased ductal secretion represents a defence mechanism in the prevention of diabetes, but further studies are needed to clarify this issue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1AnimalsMiceBicarbonatesCholecystokininCystic Fibrosis Transmembrane Conductance RegulatorPancreatic DuctsSecretin

Stichwörter der Autor:innen

CFTRdiabetesendocrine-exocrine interactionfluid and HCO3− secretionpancreatic ductal cellssecretin

Substanzen

BicarbonatesCholecystokininCystic Fibrosis Transmembrane Conductance RegulatorSecretinCftr protein, mouse

Autor:innen und Institutionen

  • Department of Pharmacology and Pharmacotherapy, University of Szeged, Szeged, Hungary.
  • ELI ALPS, ELI-HU Non-Proft Ltd, Szeged, Hungary.
  • Translational Pancreatology Research Group, Interdisciplinary Center of Excellence for Research Development and Innovation, University of Szeged, Szeged, Hungary.
  • Department of Health Sciences, Department of Theoretical and Integrative Health Sciences, University of Debrecen, Debrecen, Hungary.
  • Department of Pathology, University of Szeged, Szeged, Hungary.
  • Institute for Translational Medicine, Szentágothai Research Centre, Medical School, University of Pécs, Pécs, Hungary.

ORCID-Profile: Attila Ébert, Péter Hegyi, Viktória Venglovecz

Förderung

  • CF-Trust CFRD-SRC
  • National Research, Development and Innovation Office

Zitieren

APA

Ébert, A., Gál, E., Tóth, E., Szögi, T., Hegyi, P., & Venglovecz, V. (2024). Role of CFTR in diabetes‐induced pancreatic ductal fluid and HCO 3 − secretion. The Journal of Physiology. https://doi.org/10.1113/jp285702

Vancouver

Ébert A, Gál E, Tóth E, Szögi T, Hegyi P, Venglovecz V. Role of CFTR in diabetes‐induced pancreatic ductal fluid and HCO 3 − secretion. The Journal of Physiology. 2024. doi:10.1113/jp285702

BibTeX
@article{bert2024,
  author = {Ébert, Attila and Gál, Eleonóra and Tóth, Emese and Szögi, Titanilla and Hegyi, Péter and Venglovecz, Viktória},
  title = {Role of CFTR in diabetes‐induced pancreatic ductal fluid and HCO 3 − secretion},
  journal = {The Journal of Physiology},
  year = {2024},
  doi = {10.1113/jp285702}
}
Kostenlos starten →